Abstract Lactate uptake through monocarboxylate transporter 1 (MCT1) is associated with aggressive disease in non-small cell lung cancer (NSCLC), but how lactate transport supports tumor metabolism remains incompletely understood. Integrating stable isotope tracing, metabolomics, and transcriptomics across patient tumors, animal models, and cultured cells, we show that elevated lactate utilization and SLC16A1 expression correlate with worse clinical outcomes in NSCLC.
Robert Cameron
- Writer, Freelance
As seen in:
Medium,
Nature,
Frontiers,
MDPI,
The Conversation,
Science Magazine,
U.S. Army,
Royal Society of Chemistry,
BioRxiv,
Cell Press
and
Writer, editor, photographer, ライター、編集者、写真家、翻訳者。Runner, Japanese studier, cooker, player of guitar, bass, ukulele
Get in touch with Robert
Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack